Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

7,985 public trials 746 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

NCT01691521

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Newport Beach, California, United States
  • GSK Investigational Site Riverside, California, United States
  • GSK Investigational Site Rolling Hills Estates, California, United States
View all 134 locations
View Trial Details
Completed

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma

NCT02301975

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Huntington Beach, California, United States
  • GSK Investigational Site Riverside, California, United States
  • GSK Investigational Site Rolling Hills Estates, California, United States
  • GSK Investigational Site San Diego, California, United States
View all 179 locations
View Trial Details
Completed

Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers

NCT02098369

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Apria Healthcare Lake Forest, California, United States
  • Los Angeles Biomedical Research Institute Torrance, California, United States
  • National Jewish Health Denver, Colorado, United States
  • AlphaNet Miami, Florida, United States
View Trial Details
Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithkline (GSK) Biologicals' Investigational Vaccine GSK2838504A When Administered to Chronic Obstructive Pulmonary Disease (COPD) Patients With Persistent Airflow Obstruction.

NCT02075541

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +7 more
Locations
  • GSK Investigational Site Eskilstuna, Sweden
  • GSK Investigational Site Gothenburg, Sweden
  • GSK Investigational Site Örebro, Sweden
  • GSK Investigational Site Llanelli, Carmarthenshire, United Kingdom
View all 14 locations
View Trial Details
Completed

A Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled Asthma

NCT02567708

Conditions
Asthma, Bronchial Diseases, Chronic Disease, +11 more
Locations
  • GSK Investigational Site Munich, Bavaria, Germany
  • GSK Investigational Site Rüdersdorf, Brandenburg, Germany
  • GSK Investigational Site Frankfurt am Main, Hesse, Germany
  • GSK Investigational Site Frankfurt am Main, Hesse, Germany
View Trial Details

Related conditions